

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lymph vessel development (GO:0001945) | 6.79097686 |
| 2 | angiotensin maturation (GO:0002003) | 6.48029713 |
| 3 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.21183309 |
| 4 | transcytosis (GO:0045056) | 5.56068999 |
| 5 | endothelium development (GO:0003158) | 5.38367937 |
| 6 | regulation of acrosome reaction (GO:0060046) | 5.20811405 |
| 7 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.16978491 |
| 8 | urate metabolic process (GO:0046415) | 5.04115794 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.96167118 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.96167118 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.96167118 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.96167118 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.96167118 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.96167118 |
| 15 | renal absorption (GO:0070293) | 4.85243632 |
| 16 | lipoprotein transport (GO:0042953) | 4.81333317 |
| 17 | glomerular filtration (GO:0003094) | 4.77242008 |
| 18 | drug transmembrane transport (GO:0006855) | 4.77109879 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.71087966 |
| 20 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.57428618 |
| 21 | citrulline biosynthetic process (GO:0019240) | 4.54310690 |
| 22 | positive regulation of vasculogenesis (GO:2001214) | 4.46376107 |
| 23 | renal filtration (GO:0097205) | 4.42065780 |
| 24 | regulation of endothelial cell differentiation (GO:0045601) | 4.37876516 |
| 25 | surfactant homeostasis (GO:0043129) | 4.34312935 |
| 26 | regulation of DNA methylation (GO:0044030) | 4.29698307 |
| 27 | regulation of female gonad development (GO:2000194) | 4.24743103 |
| 28 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.20829432 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 4.12118587 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.07874827 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.06761137 |
| 32 | histamine transport (GO:0051608) | 4.06346716 |
| 33 | negative regulation of cell killing (GO:0031342) | 4.05539653 |
| 34 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.05539653 |
| 35 | endothelial cell morphogenesis (GO:0001886) | 4.01376277 |
| 36 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.00669841 |
| 37 | detection of molecule of bacterial origin (GO:0032490) | 3.91820456 |
| 38 | positive regulation of humoral immune response (GO:0002922) | 3.87921103 |
| 39 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.81426271 |
| 40 | detection of other organism (GO:0098543) | 3.80630364 |
| 41 | drug transport (GO:0015893) | 3.79167992 |
| 42 | regulation of vasculogenesis (GO:2001212) | 3.76627323 |
| 43 | Notch signaling involved in heart development (GO:0061314) | 3.73024824 |
| 44 | regulation of bile acid biosynthetic process (GO:0070857) | 3.72891390 |
| 45 | lymphangiogenesis (GO:0001946) | 3.71768486 |
| 46 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.70987777 |
| 47 | metanephric nephron epithelium development (GO:0072243) | 3.70672812 |
| 48 | histamine secretion (GO:0001821) | 3.68734125 |
| 49 | regulation of triglyceride catabolic process (GO:0010896) | 3.68432050 |
| 50 | adhesion of symbiont to host (GO:0044406) | 3.63263635 |
| 51 | epoxygenase P450 pathway (GO:0019373) | 3.60409389 |
| 52 | metanephric tubule development (GO:0072170) | 3.56834562 |
| 53 | metanephric nephron tubule development (GO:0072234) | 3.56834562 |
| 54 | polyol transport (GO:0015791) | 3.52024200 |
| 55 | L-amino acid import (GO:0043092) | 3.50262011 |
| 56 | detection of external biotic stimulus (GO:0098581) | 3.49768255 |
| 57 | hormone catabolic process (GO:0042447) | 3.49494381 |
| 58 | nephron epithelium development (GO:0072009) | 3.47415194 |
| 59 | immunoglobulin mediated immune response (GO:0016064) | 3.47096629 |
| 60 | metanephric epithelium development (GO:0072207) | 3.46322211 |
| 61 | neutrophil activation involved in immune response (GO:0002283) | 3.45691947 |
| 62 | chemical homeostasis within a tissue (GO:0048875) | 3.45028460 |
| 63 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.43639990 |
| 64 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.39957007 |
| 65 | DNA damage induced protein phosphorylation (GO:0006975) | 3.38872462 |
| 66 | oocyte development (GO:0048599) | 3.36133597 |
| 67 | phagocytosis, recognition (GO:0006910) | 3.35548113 |
| 68 | response to mercury ion (GO:0046689) | 3.35510875 |
| 69 | detection of bacterium (GO:0016045) | 3.35282649 |
| 70 | phosphate ion transport (GO:0006817) | 3.34435760 |
| 71 | heart trabecula formation (GO:0060347) | 3.32646987 |
| 72 | quaternary ammonium group transport (GO:0015697) | 3.32071547 |
| 73 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.30994385 |
| 74 | endocrine process (GO:0050886) | 3.30994385 |
| 75 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.30994385 |
| 76 | endothelial cell differentiation (GO:0045446) | 3.30411022 |
| 77 | microglial cell activation (GO:0001774) | 3.29631138 |
| 78 | endocrine hormone secretion (GO:0060986) | 3.29231335 |
| 79 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.24056843 |
| 80 | response to host immune response (GO:0052572) | 3.22989064 |
| 81 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.22989064 |
| 82 | nephron tubule development (GO:0072080) | 3.22782477 |
| 83 | glycine transport (GO:0015816) | 3.21539510 |
| 84 | blood vessel endothelial cell migration (GO:0043534) | 3.21056072 |
| 85 | blood vessel maturation (GO:0001955) | 3.19361416 |
| 86 | tonic smooth muscle contraction (GO:0014820) | 3.18783754 |
| 87 | cGMP-mediated signaling (GO:0019934) | 3.17906285 |
| 88 | patterning of blood vessels (GO:0001569) | 3.17790220 |
| 89 | respiratory burst (GO:0045730) | 3.17213158 |
| 90 | regulation of guanylate cyclase activity (GO:0031282) | 3.16340181 |
| 91 | multicellular organism reproduction (GO:0032504) | 3.15955281 |
| 92 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.15464132 |
| 93 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.12946439 |
| 94 | embryonic heart tube development (GO:0035050) | 3.12268129 |
| 95 | neutrophil activation (GO:0042119) | 3.11859479 |
| 96 | intestinal absorption (GO:0050892) | 3.11489749 |
| 97 | lysine metabolic process (GO:0006553) | 3.08239258 |
| 98 | lysine catabolic process (GO:0006554) | 3.08239258 |
| 99 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.07476496 |
| 100 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.07476496 |
| 101 | regulation of cellular extravasation (GO:0002691) | 3.05969415 |
| 102 | ovulation from ovarian follicle (GO:0001542) | 3.05960177 |
| 103 | cellular extravasation (GO:0045123) | 3.04931970 |
| 104 | endothelial tube morphogenesis (GO:0061154) | 3.03884424 |
| 105 | morphogenesis of an endothelium (GO:0003159) | 3.03884424 |
| 106 | organic cation transport (GO:0015695) | 3.01660126 |
| 107 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.01354407 |
| 108 | response to host (GO:0075136) | 3.01354407 |
| 109 | response to host defenses (GO:0052200) | 3.01354407 |
| 110 | macrophage activation (GO:0042116) | 3.00385705 |
| 111 | cytidine deamination (GO:0009972) | 3.00018261 |
| 112 | cytidine metabolic process (GO:0046087) | 3.00018261 |
| 113 | cytidine catabolic process (GO:0006216) | 3.00018261 |
| 114 | negative regulation of cell fate specification (GO:0009996) | 2.99685914 |
| 115 | sprouting angiogenesis (GO:0002040) | 2.96864143 |
| 116 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.95739059 |
| 117 | excretion (GO:0007588) | 2.92429218 |
| 118 | vasculogenesis (GO:0001570) | 2.92015197 |
| 119 | detection of biotic stimulus (GO:0009595) | 2.90208386 |
| 120 | negative regulation of endothelial cell migration (GO:0010596) | 2.88930950 |
| 121 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.88224559 |
| 122 | exogenous drug catabolic process (GO:0042738) | 2.87224307 |
| 123 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.86662517 |
| 124 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.84558871 |
| 125 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.84343384 |
| 126 | renal tubule development (GO:0061326) | 2.84132509 |
| 127 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.82639764 |
| 128 | phosphate ion transmembrane transport (GO:0035435) | 2.82245091 |
| 129 | drug catabolic process (GO:0042737) | 2.82116731 |
| 130 | regulation of systemic arterial blood pressure (GO:0003073) | 2.81758635 |
| 131 | cellular response to reactive nitrogen species (GO:1902170) | 2.80142961 |
| 132 | lung vasculature development (GO:0060426) | 2.79874640 |
| 133 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.79837613 |
| 134 | protein kinase C signaling (GO:0070528) | 2.79179016 |
| 135 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.79130988 |
| 136 | vitamin D metabolic process (GO:0042359) | 2.78829960 |
| 137 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.78520024 |
| 138 | sodium-independent organic anion transport (GO:0043252) | 2.78246993 |
| 139 | protein localization to cell surface (GO:0034394) | 2.76429993 |
| 140 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.75338411 |
| 141 | positive regulation of odontogenesis (GO:0042482) | 2.74953969 |
| 142 | response to peptidoglycan (GO:0032494) | 2.74837184 |
| 143 | leukotriene metabolic process (GO:0006691) | 2.74835170 |
| 144 | adhesion of symbiont to host cell (GO:0044650) | 2.74473313 |
| 145 | virion attachment to host cell (GO:0019062) | 2.74473313 |
| 146 | positive regulation of digestive system process (GO:0060456) | 2.74131428 |
| 147 | basement membrane organization (GO:0071711) | 2.73820842 |
| 148 | granulocyte activation (GO:0036230) | 2.72835055 |
| 149 | regulation of actin filament-based movement (GO:1903115) | 2.71149406 |
| 150 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.71082519 |
| 151 | azole transport (GO:0045117) | 2.70847705 |
| 152 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.69629805 |
| 153 | regulation of gamma-delta T cell activation (GO:0046643) | 2.68790495 |
| 154 | regulation of cellular amide metabolic process (GO:0034248) | 2.68555782 |
| 155 | citrulline metabolic process (GO:0000052) | 2.68514727 |
| 156 | drinking behavior (GO:0042756) | 2.68062507 |
| 157 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.67978061 |
| 158 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.67978061 |
| 159 | venous blood vessel morphogenesis (GO:0048845) | 2.67933043 |
| 160 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.67867123 |
| 161 | negative regulation of interleukin-12 production (GO:0032695) | 2.67324009 |
| 162 | cAMP biosynthetic process (GO:0006171) | 2.66901678 |
| 163 | establishment of endothelial barrier (GO:0061028) | 2.66116388 |
| 164 | neutrophil mediated immunity (GO:0002446) | 2.64432981 |
| 165 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.63095696 |
| 166 | endothelial cell proliferation (GO:0001935) | 2.62718358 |
| 167 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.62595193 |
| 168 | peptide catabolic process (GO:0043171) | 2.61752159 |
| 169 | interkinetic nuclear migration (GO:0022027) | 2.60866164 |
| 170 | mammary gland development (GO:0030879) | 2.59221086 |
| 171 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.59186251 |
| 172 | positive regulation of interferon-alpha production (GO:0032727) | 2.58891348 |
| 173 | I-kappaB phosphorylation (GO:0007252) | 2.58497217 |
| 174 | vitamin A metabolic process (GO:0006776) | 2.58377589 |
| 175 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.58349782 |
| 176 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.57976291 |
| 177 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.57962158 |
| 178 | regulation of mast cell degranulation (GO:0043304) | 2.57600007 |
| 179 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.55260021 |
| 180 | dendritic cell migration (GO:0036336) | 2.54586554 |
| 181 | dendritic cell chemotaxis (GO:0002407) | 2.53909490 |
| 182 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.53732418 |
| 183 | regulation of sarcomere organization (GO:0060297) | 2.53081033 |
| 184 | cellular glucuronidation (GO:0052695) | 2.51997493 |
| 185 | phosphate ion homeostasis (GO:0055062) | 2.51558968 |
| 186 | trivalent inorganic anion homeostasis (GO:0072506) | 2.51558968 |
| 187 | B cell mediated immunity (GO:0019724) | 2.51387647 |
| 188 | regulation of interferon-alpha production (GO:0032647) | 2.50682459 |
| 189 | negative regulation of epithelial cell migration (GO:0010633) | 2.50084944 |
| 190 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.49883870 |
| 191 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.47304171 |
| 192 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.46193444 |
| 193 | trabecula formation (GO:0060343) | 2.45427497 |
| 194 | renal system process (GO:0003014) | 2.44178555 |
| 195 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.43474353 |
| 196 | chondrocyte proliferation (GO:0035988) | 2.42528151 |
| 197 | artery development (GO:0060840) | 2.41641464 |
| 198 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.41621150 |
| 199 | cell migration involved in heart development (GO:0060973) | 2.40758401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.62053909 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.82245430 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.64950221 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.35955600 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.23129677 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.18166734 |
| 7 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.66495088 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.49312491 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.42128298 |
| 10 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.40478218 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.38675696 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.35391221 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.30681958 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.25911884 |
| 15 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.21306553 |
| 16 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.15744208 |
| 17 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.14682108 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.13471067 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05753095 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.01024839 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.92991805 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.90182887 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.87521536 |
| 24 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.87339814 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.85670016 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.84327257 |
| 27 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.83018200 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.82614830 |
| 29 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.82378027 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.76946799 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.71287045 |
| 32 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.71181662 |
| 33 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.67847181 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.67016175 |
| 35 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.63718347 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.63496740 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62053660 |
| 38 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.60808447 |
| 39 | CJUN_26792858_Chip-Seq_BT549_Human | 1.60436283 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.60288116 |
| 41 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.59872103 |
| 42 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.57224508 |
| 43 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.57016566 |
| 44 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56712778 |
| 45 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.56215934 |
| 46 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.53081151 |
| 47 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.52481787 |
| 48 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.52481787 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.52393455 |
| 50 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.50261066 |
| 51 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.49259663 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48114234 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.47504318 |
| 54 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.46158923 |
| 55 | VDR_22108803_ChIP-Seq_LS180_Human | 1.45019475 |
| 56 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.44479238 |
| 57 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.44166641 |
| 58 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.44013370 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.42008065 |
| 60 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.41763538 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.41712968 |
| 62 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.40299179 |
| 63 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.39938121 |
| 64 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.37883511 |
| 65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35746006 |
| 66 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.35643479 |
| 67 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.35306602 |
| 68 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.34749701 |
| 69 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34650981 |
| 70 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.33978982 |
| 71 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.33978982 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.31809116 |
| 73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.31809116 |
| 74 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.30249894 |
| 75 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29711316 |
| 76 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.29500865 |
| 77 | RXR_22108803_ChIP-Seq_LS180_Human | 1.28559579 |
| 78 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28351602 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27793396 |
| 80 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.27014377 |
| 81 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.26017109 |
| 82 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.24506941 |
| 83 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.24219126 |
| 84 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.23998199 |
| 85 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21623505 |
| 86 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.20530473 |
| 87 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.19633318 |
| 88 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.17934067 |
| 89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17506121 |
| 90 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16682431 |
| 91 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.16646235 |
| 92 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.15722377 |
| 93 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14974036 |
| 94 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14214894 |
| 95 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.13320653 |
| 96 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.11825122 |
| 97 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.11601589 |
| 98 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11457797 |
| 99 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.11232301 |
| 100 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11209087 |
| 101 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10669617 |
| 102 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.09790696 |
| 103 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09466745 |
| 104 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.08631603 |
| 105 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.07979969 |
| 106 | TP53_16413492_ChIP-PET_HCT116_Human | 1.07527126 |
| 107 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05829865 |
| 108 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02637179 |
| 109 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01489738 |
| 110 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01205664 |
| 111 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.00708536 |
| 112 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99759907 |
| 113 | MYB_26560356_Chip-Seq_TH1_Human | 0.99494721 |
| 114 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98950438 |
| 115 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.98443025 |
| 116 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.97609793 |
| 117 | MYB_26560356_Chip-Seq_TH2_Human | 0.96670237 |
| 118 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.96119614 |
| 119 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.96056077 |
| 120 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.95913351 |
| 121 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.95417897 |
| 122 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93366737 |
| 123 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.92042250 |
| 124 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.91774715 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91528723 |
| 126 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.91268205 |
| 127 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.91268205 |
| 128 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.91249532 |
| 129 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90832218 |
| 130 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.90570429 |
| 131 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.90296770 |
| 132 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.90264592 |
| 133 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.89767747 |
| 134 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.89761393 |
| 135 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89713759 |
| 136 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89413639 |
| 137 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88634315 |
| 138 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88619933 |
| 139 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.88053979 |
| 140 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.88053979 |
| 141 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.88053979 |
| 142 | P300_19829295_ChIP-Seq_ESCs_Human | 0.87917919 |
| 143 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87533534 |
| 144 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.87222910 |
| 145 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.86904661 |
| 146 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86900418 |
| 147 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.86307061 |
| 148 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.86048645 |
| 149 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85964683 |
| 150 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.85848923 |
| 151 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85313972 |
| 152 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85068649 |
| 153 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.84953424 |
| 154 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.84285335 |
| 155 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.84259117 |
| 156 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83944930 |
| 157 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.82382082 |
| 158 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.81792452 |
| 159 | GATA3_26560356_Chip-Seq_TH2_Human | 0.80323499 |
| 160 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79830280 |
| 161 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79626978 |
| 162 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79039198 |
| 163 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.78787079 |
| 164 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.78407734 |
| 165 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.78125471 |
| 166 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76789121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001879_abnormal_lymphatic_vessel | 5.03662946 |
| 2 | MP0003183_abnormal_peptide_metabolism | 4.91587549 |
| 3 | MP0010368_abnormal_lymphatic_system | 3.84647650 |
| 4 | MP0005360_urolithiasis | 3.70750923 |
| 5 | MP0003724_increased_susceptibility_to | 3.59744511 |
| 6 | MP0005167_abnormal_blood-brain_barrier | 3.44659302 |
| 7 | MP0003718_maternal_effect | 3.39127916 |
| 8 | MP0006054_spinal_hemorrhage | 3.37634239 |
| 9 | MP0004272_abnormal_basement_membrane | 3.16558572 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.96413763 |
| 11 | MP0004147_increased_porphyrin_level | 2.83870258 |
| 12 | MP0003828_pulmonary_edema | 2.78116771 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.76578899 |
| 14 | MP0009840_abnormal_foam_cell | 2.73245826 |
| 15 | MP0005377_hearing/vestibular/ear_phenot | 2.62338098 |
| 16 | MP0003878_abnormal_ear_physiology | 2.62338098 |
| 17 | MP0003303_peritoneal_inflammation | 2.60249524 |
| 18 | MP0003436_decreased_susceptibility_to | 2.56255959 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.49094566 |
| 20 | MP0004043_abnormal_pH_regulation | 2.46472804 |
| 21 | MP0010155_abnormal_intestine_physiology | 2.30045302 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 2.28268988 |
| 23 | MP0005365_abnormal_bile_salt | 2.27930262 |
| 24 | MP0004484_altered_response_of | 2.27002643 |
| 25 | MP0001835_abnormal_antigen_presentation | 2.01273308 |
| 26 | MP0001958_emphysema | 2.01050052 |
| 27 | MP0003879_abnormal_hair_cell | 1.99317607 |
| 28 | MP0009785_altered_susceptibility_to | 1.94660852 |
| 29 | MP0000465_gastrointestinal_hemorrhage | 1.93539290 |
| 30 | MP0004084_abnormal_cardiac_muscle | 1.92256849 |
| 31 | MP0001756_abnormal_urination | 1.91786802 |
| 32 | MP0002419_abnormal_innate_immunity | 1.89162717 |
| 33 | MP0003941_abnormal_skin_development | 1.84645614 |
| 34 | MP0006138_congestive_heart_failure | 1.83812802 |
| 35 | MP0000767_abnormal_smooth_muscle | 1.81804808 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.80909355 |
| 37 | MP0005025_abnormal_response_to | 1.77775649 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.74046029 |
| 39 | MP0005171_absent_coat_pigmentation | 1.70133043 |
| 40 | MP0001664_abnormal_digestion | 1.68383676 |
| 41 | MP0004215_abnormal_myocardial_fiber | 1.65993736 |
| 42 | MP0003252_abnormal_bile_duct | 1.65927016 |
| 43 | MP0008260_abnormal_autophagy | 1.62293943 |
| 44 | MP0005503_abnormal_tendon_morphology | 1.62218901 |
| 45 | MP0002127_abnormal_cardiovascular_syste | 1.60008620 |
| 46 | MP0005395_other_phenotype | 1.59034823 |
| 47 | MP0008775_abnormal_heart_ventricle | 1.58541125 |
| 48 | MP0001765_abnormal_ion_homeostasis | 1.57883342 |
| 49 | MP0005670_abnormal_white_adipose | 1.56458298 |
| 50 | MP0005330_cardiomyopathy | 1.55227939 |
| 51 | MP0003866_abnormal_defecation | 1.52916687 |
| 52 | MP0005332_abnormal_amino_acid | 1.51422501 |
| 53 | MP0001800_abnormal_humoral_immune | 1.50894773 |
| 54 | MP0002972_abnormal_cardiac_muscle | 1.49628750 |
| 55 | MP0006082_CNS_inflammation | 1.49447532 |
| 56 | MP0009697_abnormal_copulation | 1.49363076 |
| 57 | MP0002136_abnormal_kidney_physiology | 1.47823078 |
| 58 | MP0005084_abnormal_gallbladder_morpholo | 1.46840849 |
| 59 | MP0003950_abnormal_plasma_membrane | 1.43557349 |
| 60 | MP0000230_abnormal_systemic_arterial | 1.42016939 |
| 61 | MP0004270_analgesia | 1.41500686 |
| 62 | MP0004036_abnormal_muscle_relaxation | 1.41290475 |
| 63 | MP0005451_abnormal_body_composition | 1.40016823 |
| 64 | MP0002723_abnormal_immune_serum | 1.39520282 |
| 65 | MP0005000_abnormal_immune_tolerance | 1.38285671 |
| 66 | MP0003279_aneurysm | 1.38086177 |
| 67 | MP0003567_abnormal_fetal_cardiomyocyte | 1.36317033 |
| 68 | MP0002420_abnormal_adaptive_immunity | 1.36221449 |
| 69 | MP0001790_abnormal_immune_system | 1.36152204 |
| 70 | MP0005387_immune_system_phenotype | 1.36152204 |
| 71 | MP0001544_abnormal_cardiovascular_syste | 1.35769801 |
| 72 | MP0005385_cardiovascular_system_phenoty | 1.35769801 |
| 73 | MP0005620_abnormal_muscle_contractility | 1.35181740 |
| 74 | MP0001819_abnormal_immune_cell | 1.35013710 |
| 75 | MP0001533_abnormal_skeleton_physiology | 1.33083932 |
| 76 | MP0005623_abnormal_meninges_morphology | 1.32907867 |
| 77 | MP0010329_abnormal_lipoprotein_level | 1.30119290 |
| 78 | MP0005166_decreased_susceptibility_to | 1.27951760 |
| 79 | MP0003868_abnormal_feces_composition | 1.27671292 |
| 80 | MP0002277_abnormal_respiratory_mucosa | 1.25932000 |
| 81 | MP0002452_abnormal_antigen_presenting | 1.25876519 |
| 82 | MP0005165_increased_susceptibility_to | 1.25490168 |
| 83 | MP0009379_abnormal_foot_pigmentation | 1.25250190 |
| 84 | MP0005595_abnormal_vascular_smooth | 1.24180644 |
| 85 | MP0003300_gastrointestinal_ulcer | 1.23882212 |
| 86 | MP0000343_altered_response_to | 1.23165265 |
| 87 | MP0001845_abnormal_inflammatory_respons | 1.21144437 |
| 88 | MP0000685_abnormal_immune_system | 1.20507255 |
| 89 | MP0008469_abnormal_protein_level | 1.18518678 |
| 90 | MP0000516_abnormal_urinary_system | 1.17891714 |
| 91 | MP0005367_renal/urinary_system_phenotyp | 1.17891714 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 1.16280448 |
| 93 | MP0000249_abnormal_blood_vessel | 1.15816774 |
| 94 | MP0004883_abnormal_blood_vessel | 1.15477851 |
| 95 | MP0002148_abnormal_hypersensitivity_rea | 1.15156684 |
| 96 | MP0003763_abnormal_thymus_physiology | 1.14975519 |
| 97 | MP0010630_abnormal_cardiac_muscle | 1.14634702 |
| 98 | MP0003191_abnormal_cellular_cholesterol | 1.12126275 |
| 99 | MP0005636_abnormal_mineral_homeostasis | 1.07250706 |
| 100 | MP0000762_abnormal_tongue_morphology | 1.05339722 |
| 101 | MP0003122_maternal_imprinting | 1.04559948 |
| 102 | MP0000751_myopathy | 1.02888288 |
| 103 | MP0003045_fibrosis | 1.02109929 |
| 104 | MP0001270_distended_abdomen | 1.02095037 |
| 105 | MP0002925_abnormal_cardiovascular_devel | 1.02011103 |
| 106 | MP0002295_abnormal_pulmonary_circulatio | 1.00322717 |
| 107 | MP0005671_abnormal_response_to | 0.98505391 |
| 108 | MP0002108_abnormal_muscle_morphology | 0.97773420 |
| 109 | MP0000537_abnormal_urethra_morphology | 0.97324211 |
| 110 | MP0010234_abnormal_vibrissa_follicle | 0.96801262 |
| 111 | MP0003385_abnormal_body_wall | 0.95685151 |
| 112 | MP0005409_darkened_coat_color | 0.95329861 |
| 113 | MP0000566_synostosis | 0.94863219 |
| 114 | MP0004947_skin_inflammation | 0.94519038 |
| 115 | MP0003943_abnormal_hepatobiliary_system | 0.93877698 |
| 116 | MP0004085_abnormal_heartbeat | 0.93671738 |
| 117 | MP0002132_abnormal_respiratory_system | 0.93651862 |
| 118 | MP0000538_abnormal_urinary_bladder | 0.92503735 |
| 119 | MP0008004_abnormal_stomach_pH | 0.92458305 |
| 120 | MP0001614_abnormal_blood_vessel | 0.92119232 |
| 121 | MP0000716_abnormal_immune_system | 0.92074094 |
| 122 | MP0005164_abnormal_response_to | 0.91921474 |
| 123 | MP0002118_abnormal_lipid_homeostasis | 0.90673440 |
| 124 | MP0008877_abnormal_DNA_methylation | 0.90657685 |
| 125 | MP0003448_altered_tumor_morphology | 0.90092778 |
| 126 | MP0002128_abnormal_blood_circulation | 0.89779577 |
| 127 | MP0002896_abnormal_bone_mineralization | 0.89268162 |
| 128 | MP0000749_muscle_degeneration | 0.88693353 |
| 129 | MP0003699_abnormal_female_reproductive | 0.88480012 |
| 130 | MP0002332_abnormal_exercise_endurance | 0.88461601 |
| 131 | MP0000013_abnormal_adipose_tissue | 0.85000738 |
| 132 | MP0000015_abnormal_ear_pigmentation | 0.84969699 |
| 133 | MP0005085_abnormal_gallbladder_physiolo | 0.79978349 |
| 134 | MP0004264_abnormal_extraembryonic_tissu | 0.79337030 |
| 135 | MP0003566_abnormal_cell_adhesion | 0.78253830 |
| 136 | MP0002998_abnormal_bone_remodeling | 0.78188556 |
| 137 | MP0003806_abnormal_nucleotide_metabolis | 0.77366232 |
| 138 | MP0001784_abnormal_fluid_regulation | 0.77215960 |
| 139 | MP0000266_abnormal_heart_morphology | 0.76861347 |
| 140 | MP0000534_abnormal_ureter_morphology | 0.76786000 |
| 141 | MP0009764_decreased_sensitivity_to | 0.76770282 |
| 142 | MP0001873_stomach_inflammation | 0.76302941 |
| 143 | MP0009115_abnormal_fat_cell | 0.75962486 |
| 144 | MP0009780_abnormal_chondrocyte_physiolo | 0.75686526 |
| 145 | MP0005535_abnormal_body_temperature | 0.75454470 |
| 146 | MP0002098_abnormal_vibrissa_morphology | 0.74954513 |
| 147 | MP0001501_abnormal_sleep_pattern | 0.74429603 |
| 148 | MP0002133_abnormal_respiratory_system | 0.74177874 |
| 149 | MP0005388_respiratory_system_phenotype | 0.74177874 |
| 150 | MP0005376_homeostasis/metabolism_phenot | 0.74127486 |
| 151 | MP0001663_abnormal_digestive_system | 0.73219456 |
| 152 | MP0009278_abnormal_bone_marrow | 0.73090974 |
| 153 | MP0002398_abnormal_bone_marrow | 0.72469324 |
| 154 | MP0000490_abnormal_crypts_of | 0.71918841 |
| 155 | MP0004145_abnormal_muscle_electrophysio | 0.71665638 |
| 156 | MP0010386_abnormal_urinary_bladder | 0.71443001 |
| 157 | MP0002405_respiratory_system_inflammati | 0.69030592 |
| 158 | MP0004087_abnormal_muscle_fiber | 0.68504128 |
| 159 | MP0005248_abnormal_Harderian_gland | 0.68145007 |
| 160 | MP0005448_abnormal_energy_balance | 0.67776348 |
| 161 | MP0008961_abnormal_basal_metabolism | 0.67575075 |
| 162 | MP0004381_abnormal_hair_follicle | 0.67440528 |
| 163 | MP0002928_abnormal_bile_duct | 0.67239538 |
| 164 | MP0005187_abnormal_penis_morphology | 0.64614718 |
| 165 | MP0002722_abnormal_immune_system | 0.63461748 |
| 166 | MP0008874_decreased_physiological_sensi | 0.61799835 |
| 167 | MP0003075_altered_response_to | 0.61693547 |
| 168 | MP0005334_abnormal_fat_pad | 0.60163545 |
| 169 | MP0000609_abnormal_liver_physiology | 0.60125410 |
| 170 | MP0000678_abnormal_parathyroid_gland | 0.58727509 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolic alkalosis (HP:0200114) | 6.24945694 |
| 2 | Hyperactive renin-angiotensin system (HP:0000841) | 5.88519555 |
| 3 | Increased circulating renin level (HP:0000848) | 5.71500194 |
| 4 | Hypokalemic alkalosis (HP:0001949) | 5.34450064 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.27455029 |
| 6 | Abnormality of chloride homeostasis (HP:0011422) | 5.12819713 |
| 7 | Orchitis (HP:0100796) | 4.77616801 |
| 8 | Polyuria (HP:0000103) | 4.77102406 |
| 9 | Hypomagnesemia (HP:0002917) | 4.75322500 |
| 10 | Abnormal urine output (HP:0012590) | 4.62068642 |
| 11 | Myositis (HP:0100614) | 4.57066397 |
| 12 | Abnormality of renal excretion (HP:0011036) | 4.43183435 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 4.37637017 |
| 14 | Optic neuritis (HP:0100653) | 4.37637017 |
| 15 | Abnormality of renin-angiotensin system (HP:0000847) | 4.13154954 |
| 16 | Polydipsia (HP:0001959) | 4.10177070 |
| 17 | Abnormal drinking behavior (HP:0030082) | 4.10177070 |
| 18 | Abnormality of magnesium homeostasis (HP:0004921) | 4.04154216 |
| 19 | Proximal tubulopathy (HP:0000114) | 4.03890748 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.96869296 |
| 21 | Hyperaldosteronism (HP:0000859) | 3.92998604 |
| 22 | Tetany (HP:0001281) | 3.91885911 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.83121825 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 3.82285069 |
| 25 | Chronic diarrhea (HP:0002028) | 3.75612203 |
| 26 | Gingivitis (HP:0000230) | 3.66082319 |
| 27 | Gout (HP:0001997) | 3.63286114 |
| 28 | Aortic aneurysm (HP:0004942) | 3.46552032 |
| 29 | Osteomalacia (HP:0002749) | 3.45447240 |
| 30 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.42097262 |
| 31 | Alkalosis (HP:0001948) | 3.39387150 |
| 32 | Lymphangioma (HP:0100764) | 3.35717836 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 3.33346565 |
| 34 | Fat malabsorption (HP:0002630) | 3.32929827 |
| 35 | Congenital sensorineural hearing impairment (HP:0008527) | 3.24117383 |
| 36 | Hyperuricemia (HP:0002149) | 3.20992964 |
| 37 | Increased purine levels (HP:0004368) | 3.20992964 |
| 38 | Keratoconjunctivitis sicca (HP:0001097) | 3.19966017 |
| 39 | Hypokalemia (HP:0002900) | 3.15851650 |
| 40 | Distal lower limb muscle weakness (HP:0009053) | 3.14756919 |
| 41 | Stomatitis (HP:0010280) | 3.13556864 |
| 42 | Hypobetalipoproteinemia (HP:0003563) | 3.08934060 |
| 43 | Facial diplegia (HP:0001349) | 3.08051475 |
| 44 | Encephalitis (HP:0002383) | 3.06378470 |
| 45 | Renal salt wasting (HP:0000127) | 3.05883709 |
| 46 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.97080419 |
| 47 | Acanthocytosis (HP:0001927) | 2.94811029 |
| 48 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.93900242 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.87407135 |
| 50 | Keratoconjunctivitis (HP:0001096) | 2.86562749 |
| 51 | Muscle fiber splitting (HP:0003555) | 2.84455433 |
| 52 | Hypophosphatemic rickets (HP:0004912) | 2.80676086 |
| 53 | Hypercalciuria (HP:0002150) | 2.78717282 |
| 54 | Hyperglycinuria (HP:0003108) | 2.76530200 |
| 55 | Abnormality of potassium homeostasis (HP:0011042) | 2.75526601 |
| 56 | Enlarged epiphyses (HP:0010580) | 2.73574680 |
| 57 | Papillary thyroid carcinoma (HP:0002895) | 2.72562709 |
| 58 | Pigmentary retinal degeneration (HP:0001146) | 2.70803812 |
| 59 | Abnormality of vitamin B metabolism (HP:0004340) | 2.70034772 |
| 60 | Esophageal varix (HP:0002040) | 2.68904019 |
| 61 | Generalized aminoaciduria (HP:0002909) | 2.68045757 |
| 62 | Absent eyebrow (HP:0002223) | 2.67784578 |
| 63 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.65386285 |
| 64 | Recurrent fungal infections (HP:0002841) | 2.54223462 |
| 65 | Thin bony cortex (HP:0002753) | 2.51038313 |
| 66 | Impulsivity (HP:0100710) | 2.50377640 |
| 67 | Vasculitis (HP:0002633) | 2.49872297 |
| 68 | Hemoptysis (HP:0002105) | 2.48677536 |
| 69 | Widely patent fontanelles and sutures (HP:0004492) | 2.48323479 |
| 70 | Peritonitis (HP:0002586) | 2.46395474 |
| 71 | Aortic dissection (HP:0002647) | 2.44816299 |
| 72 | Abnormality of urine glucose concentration (HP:0011016) | 2.41643448 |
| 73 | Glycosuria (HP:0003076) | 2.41643448 |
| 74 | Renal tubular acidosis (HP:0001947) | 2.40953265 |
| 75 | Hematochezia (HP:0002573) | 2.40509200 |
| 76 | Polycythemia (HP:0001901) | 2.39412644 |
| 77 | Meningitis (HP:0001287) | 2.38536459 |
| 78 | Ketoacidosis (HP:0001993) | 2.37699161 |
| 79 | Steatorrhea (HP:0002570) | 2.37486276 |
| 80 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.36580653 |
| 81 | Abnormality of proline metabolism (HP:0010907) | 2.36421946 |
| 82 | Hydroxyprolinuria (HP:0003080) | 2.36421946 |
| 83 | Ventricular fibrillation (HP:0001663) | 2.36246276 |
| 84 | Hypoplasia of the iris (HP:0007676) | 2.34698204 |
| 85 | Hypophosphatemia (HP:0002148) | 2.32959008 |
| 86 | Increased connective tissue (HP:0009025) | 2.30187028 |
| 87 | Atrial fibrillation (HP:0005110) | 2.29786450 |
| 88 | Potter facies (HP:0002009) | 2.29497865 |
| 89 | Facial shape deformation (HP:0011334) | 2.29497865 |
| 90 | Amyloidosis (HP:0011034) | 2.28950764 |
| 91 | Osteomyelitis (HP:0002754) | 2.28822988 |
| 92 | Generalized muscle weakness (HP:0003324) | 2.25824915 |
| 93 | Confusion (HP:0001289) | 2.24886534 |
| 94 | Aplasia of the musculature (HP:0100854) | 2.23751408 |
| 95 | Vascular calcification (HP:0004934) | 2.23158125 |
| 96 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.22539798 |
| 97 | Autoimmune thrombocytopenia (HP:0001973) | 2.21432506 |
| 98 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.20835392 |
| 99 | Chest pain (HP:0100749) | 2.20376308 |
| 100 | Absent hand (HP:0004050) | 2.20229740 |
| 101 | Recurrent skin infections (HP:0001581) | 2.20092521 |
| 102 | Ileus (HP:0002595) | 2.20009534 |
| 103 | Sudden death (HP:0001699) | 2.18940816 |
| 104 | Decreased circulating renin level (HP:0003351) | 2.18542268 |
| 105 | Abnormality of the costochondral junction (HP:0000919) | 2.17960535 |
| 106 | Aplasia cutis congenita (HP:0001057) | 2.17643551 |
| 107 | Colitis (HP:0002583) | 2.17172541 |
| 108 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.16897990 |
| 109 | Urticaria (HP:0001025) | 2.16873715 |
| 110 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.14778073 |
| 111 | Nausea (HP:0002018) | 2.14631760 |
| 112 | Mediastinal lymphadenopathy (HP:0100721) | 2.13372736 |
| 113 | Vascular tortuosity (HP:0004948) | 2.12965784 |
| 114 | Loss of speech (HP:0002371) | 2.11812459 |
| 115 | Ventricular tachycardia (HP:0004756) | 2.11024710 |
| 116 | Cardiovascular calcification (HP:0011915) | 2.10715674 |
| 117 | Abnormality of the calf musculature (HP:0001430) | 2.08246733 |
| 118 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.06710592 |
| 119 | Elevated alkaline phosphatase (HP:0003155) | 2.04906281 |
| 120 | Pulmonary infiltrates (HP:0002113) | 2.02798754 |
| 121 | Subacute progressive viral hepatitis (HP:0006572) | 2.02672702 |
| 122 | Posterior subcapsular cataract (HP:0007787) | 2.02217698 |
| 123 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.02104734 |
| 124 | Chondrocalcinosis (HP:0000934) | 2.01033541 |
| 125 | Primary atrial arrhythmia (HP:0001692) | 2.00971744 |
| 126 | Abnormality of vitamin metabolism (HP:0100508) | 2.00460584 |
| 127 | Obstructive lung disease (HP:0006536) | 1.99073299 |
| 128 | Chronic obstructive pulmonary disease (HP:0006510) | 1.99073299 |
| 129 | Portal hypertension (HP:0001409) | 1.98246208 |
| 130 | Nonimmune hydrops fetalis (HP:0001790) | 1.97852521 |
| 131 | Hip contracture (HP:0003273) | 1.97277967 |
| 132 | Absent eyelashes (HP:0000561) | 1.97147643 |
| 133 | Dehydration (HP:0001944) | 1.96648313 |
| 134 | Adactyly (HP:0009776) | 1.96467288 |
| 135 | Supraventricular arrhythmia (HP:0005115) | 1.96037210 |
| 136 | Anorexia (HP:0002039) | 1.95903120 |
| 137 | Abnormality of Sharpey fibers (HP:0100685) | 1.95494738 |
| 138 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.95442776 |
| 139 | Right ventricular cardiomyopathy (HP:0011663) | 1.95309942 |
| 140 | Cheilitis (HP:0100825) | 1.94896536 |
| 141 | Difficulty running (HP:0009046) | 1.94874639 |
| 142 | Pulmonary artery stenosis (HP:0004415) | 1.94712535 |
| 143 | Diaphragmatic weakness (HP:0009113) | 1.93388278 |
| 144 | Cellulitis (HP:0100658) | 1.93017728 |
| 145 | Increased IgE level (HP:0003212) | 1.91588600 |
| 146 | Wide cranial sutures (HP:0010537) | 1.90899187 |
| 147 | Episodic fever (HP:0001954) | 1.90783652 |
| 148 | Enlarged kidneys (HP:0000105) | 1.90025182 |
| 149 | Neonatal death (HP:0003811) | 1.89460040 |
| 150 | Arterial thrombosis (HP:0004420) | 1.89397293 |
| 151 | Mesangial abnormality (HP:0001966) | 1.89144070 |
| 152 | Abnormality of glycine metabolism (HP:0010895) | 1.89035606 |
| 153 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.89035606 |
| 154 | Shawl scrotum (HP:0000049) | 1.88765314 |
| 155 | Pulmonary embolism (HP:0002204) | 1.88401734 |
| 156 | Prolonged QT interval (HP:0001657) | 1.88221758 |
| 157 | Skin rash (HP:0000988) | 1.87908690 |
| 158 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.86331344 |
| 159 | Systemic lupus erythematosus (HP:0002725) | 1.85720042 |
| 160 | Subcapsular cataract (HP:0000523) | 1.84455010 |
| 161 | Supraventricular tachycardia (HP:0004755) | 1.83301623 |
| 162 | Rickets (HP:0002748) | 1.83182572 |
| 163 | Inflammation of the large intestine (HP:0002037) | 1.81865536 |
| 164 | Exercise-induced muscle cramps (HP:0003710) | 1.81478820 |
| 165 | Abnormality of the endocardium (HP:0004306) | 1.81192353 |
| 166 | Abnormal urine phosphate concentration (HP:0012599) | 1.80978762 |
| 167 | Hypoglycemic coma (HP:0001325) | 1.79128142 |
| 168 | Spontaneous hematomas (HP:0007420) | 1.78896708 |
| 169 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.78661885 |
| 170 | Hypoplasia of the fovea (HP:0007750) | 1.78661885 |
| 171 | Malnutrition (HP:0004395) | 1.78180022 |
| 172 | Toxemia of pregnancy (HP:0100603) | 1.77405819 |
| 173 | Nephrolithiasis (HP:0000787) | 1.75639739 |
| 174 | Pancreatitis (HP:0001733) | 1.75324165 |
| 175 | Abnormality of the hepatic vasculature (HP:0006707) | 1.74710333 |
| 176 | Lipoatrophy (HP:0100578) | 1.74097502 |
| 177 | Acne (HP:0001061) | 1.73508795 |
| 178 | Alopecia of scalp (HP:0002293) | 1.71995438 |
| 179 | Metaphyseal irregularity (HP:0003025) | 1.71518384 |
| 180 | Visceral angiomatosis (HP:0100761) | 1.70446024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 7.35736939 |
| 2 | KDR | 4.19210301 |
| 3 | PDK2 | 3.98883918 |
| 4 | WNK4 | 3.72837376 |
| 5 | MYLK | 3.58946278 |
| 6 | ACVR1B | 3.54093972 |
| 7 | MAP2K6 | 3.42234188 |
| 8 | RIPK4 | 3.26838858 |
| 9 | OXSR1 | 2.86995487 |
| 10 | AKT3 | 2.86568261 |
| 11 | TGFBR2 | 2.77726415 |
| 12 | WNK3 | 2.73375074 |
| 13 | MAP3K5 | 2.71573917 |
| 14 | TAOK3 | 2.43624213 |
| 15 | EPHB2 | 2.23946679 |
| 16 | INSRR | 2.08768554 |
| 17 | STK39 | 2.08340187 |
| 18 | RIPK1 | 2.07157288 |
| 19 | TYK2 | 2.02285214 |
| 20 | MAP3K13 | 1.98610494 |
| 21 | SIK2 | 1.90850458 |
| 22 | TGFBR1 | 1.84360049 |
| 23 | KSR2 | 1.83003524 |
| 24 | FER | 1.79570449 |
| 25 | TLK1 | 1.77333580 |
| 26 | NUAK1 | 1.60613922 |
| 27 | STK38L | 1.54246066 |
| 28 | BLK | 1.52122883 |
| 29 | PTK2B | 1.51560939 |
| 30 | MAP3K3 | 1.46106642 |
| 31 | SIK3 | 1.42965501 |
| 32 | MAP3K14 | 1.36849439 |
| 33 | FRK | 1.36001213 |
| 34 | DMPK | 1.30036485 |
| 35 | MAP4K1 | 1.28213586 |
| 36 | NEK6 | 1.28202294 |
| 37 | TTN | 1.23622602 |
| 38 | GRK1 | 1.22903668 |
| 39 | MELK | 1.20910211 |
| 40 | TNK2 | 1.19642089 |
| 41 | MAPK12 | 1.18107689 |
| 42 | GRK6 | 1.16703388 |
| 43 | ZAK | 1.16303179 |
| 44 | STK24 | 1.15791537 |
| 45 | MAP3K2 | 1.15443548 |
| 46 | PTK6 | 1.13551314 |
| 47 | LATS1 | 1.13276314 |
| 48 | ZAP70 | 1.10922934 |
| 49 | IRAK1 | 1.09373264 |
| 50 | MAP3K8 | 1.08831265 |
| 51 | JAK2 | 1.08543546 |
| 52 | BCKDK | 1.05992227 |
| 53 | MAP3K1 | 1.05941126 |
| 54 | TAOK1 | 1.01862234 |
| 55 | JAK1 | 1.01861887 |
| 56 | LMTK2 | 0.97825431 |
| 57 | DDR2 | 0.95463402 |
| 58 | WNK1 | 0.95369620 |
| 59 | MAPK15 | 0.94588159 |
| 60 | PIM1 | 0.94103064 |
| 61 | JAK3 | 0.93822893 |
| 62 | HCK | 0.93535625 |
| 63 | PDK1 | 0.92711198 |
| 64 | OBSCN | 0.92478545 |
| 65 | RAF1 | 0.91827847 |
| 66 | MAP3K9 | 0.90528557 |
| 67 | MAPK7 | 0.88733731 |
| 68 | YES1 | 0.85075381 |
| 69 | FES | 0.84744054 |
| 70 | MATK | 0.84581331 |
| 71 | IRAK3 | 0.83726672 |
| 72 | ARAF | 0.83535365 |
| 73 | BMPR1B | 0.81918085 |
| 74 | SGK223 | 0.81727982 |
| 75 | SGK494 | 0.81727982 |
| 76 | MARK2 | 0.81033802 |
| 77 | RET | 0.78739611 |
| 78 | PIK3CA | 0.76607406 |
| 79 | MAP3K7 | 0.76032574 |
| 80 | MARK3 | 0.75131329 |
| 81 | PRKCZ | 0.74440411 |
| 82 | GSK3A | 0.74359965 |
| 83 | NLK | 0.72929170 |
| 84 | SGK2 | 0.72125323 |
| 85 | EPHB1 | 0.72096265 |
| 86 | BTK | 0.70754107 |
| 87 | MST4 | 0.70258030 |
| 88 | KSR1 | 0.70190334 |
| 89 | SIK1 | 0.70125694 |
| 90 | PAK4 | 0.69945621 |
| 91 | BCR | 0.68975875 |
| 92 | FGR | 0.67816724 |
| 93 | MAP3K6 | 0.67354810 |
| 94 | EPHA3 | 0.66661139 |
| 95 | IRAK2 | 0.66261221 |
| 96 | PRKG2 | 0.66101163 |
| 97 | PRKAA2 | 0.64503646 |
| 98 | TXK | 0.64433955 |
| 99 | ERN1 | 0.63621054 |
| 100 | CDK8 | 0.63367943 |
| 101 | EPHA2 | 0.63074841 |
| 102 | SYK | 0.62859719 |
| 103 | LYN | 0.61888959 |
| 104 | PDK4 | 0.61104518 |
| 105 | PDK3 | 0.61104518 |
| 106 | MAP3K11 | 0.58999243 |
| 107 | TESK2 | 0.55943152 |
| 108 | MST1R | 0.55765180 |
| 109 | CDK19 | 0.55191138 |
| 110 | BMPR2 | 0.52307013 |
| 111 | PAK2 | 0.51752768 |
| 112 | MAP2K2 | 0.51326320 |
| 113 | PRPF4B | 0.51170439 |
| 114 | LCK | 0.49027726 |
| 115 | MOS | 0.47450649 |
| 116 | SGK3 | 0.46065743 |
| 117 | CDK12 | 0.45590632 |
| 118 | TRPM7 | 0.45041003 |
| 119 | TNIK | 0.44823861 |
| 120 | PRKCH | 0.43855697 |
| 121 | MAPKAPK3 | 0.43520315 |
| 122 | PTK2 | 0.43354472 |
| 123 | TBK1 | 0.43274350 |
| 124 | STK11 | 0.43136225 |
| 125 | NEK9 | 0.41130550 |
| 126 | MET | 0.39631405 |
| 127 | TSSK6 | 0.39283626 |
| 128 | CAMK4 | 0.39208634 |
| 129 | IGF1R | 0.39195499 |
| 130 | FGFR4 | 0.38572408 |
| 131 | CSF1R | 0.38449402 |
| 132 | PRKCE | 0.38118632 |
| 133 | PRKD1 | 0.38022577 |
| 134 | IRAK4 | 0.37735312 |
| 135 | LRRK2 | 0.37668932 |
| 136 | FYN | 0.36966519 |
| 137 | ROCK1 | 0.35977167 |
| 138 | MAP2K4 | 0.34883475 |
| 139 | KIT | 0.34838302 |
| 140 | MAP2K1 | 0.33261479 |
| 141 | IKBKE | 0.32772699 |
| 142 | PRKAA1 | 0.32410660 |
| 143 | TAOK2 | 0.32349375 |
| 144 | MAP2K3 | 0.31706239 |
| 145 | CAMK1 | 0.31000527 |
| 146 | TEC | 0.30796830 |
| 147 | PDGFRA | 0.30399392 |
| 148 | PHKG2 | 0.30136832 |
| 149 | PHKG1 | 0.30136832 |
| 150 | STK3 | 0.29257328 |
| 151 | MAP3K12 | 0.29239210 |
| 152 | LATS2 | 0.29086332 |
| 153 | PAK3 | 0.29030154 |
| 154 | PIK3CG | 0.27977459 |
| 155 | INSR | 0.27324741 |
| 156 | ERBB2 | 0.27243172 |
| 157 | SGK1 | 0.26401783 |
| 158 | CSK | 0.25641020 |
| 159 | AKT2 | 0.24213869 |
| 160 | CDC42BPA | 0.23951244 |
| 161 | PDPK1 | 0.23918525 |
| 162 | FGFR3 | 0.22550857 |
| 163 | CDK9 | 0.21903098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.45709913 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.60355333 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.50033479 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.39522457 |
| 5 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.12048976 |
| 6 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.08455755 |
| 7 | Mineral absorption_Homo sapiens_hsa04978 | 2.04041401 |
| 8 | Bile secretion_Homo sapiens_hsa04976 | 2.02281273 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.02020251 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.00752562 |
| 11 | Adherens junction_Homo sapiens_hsa04520 | 1.95716350 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.93044838 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86189078 |
| 14 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.81191622 |
| 15 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.80690505 |
| 16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.80501158 |
| 17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.77015552 |
| 18 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.69271684 |
| 19 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.65159197 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.62289015 |
| 21 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.62053909 |
| 22 | Focal adhesion_Homo sapiens_hsa04510 | 1.61441772 |
| 23 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.61419447 |
| 24 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.59815487 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59654723 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.53494514 |
| 27 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.47041528 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.46435065 |
| 29 | Tight junction_Homo sapiens_hsa04530 | 1.45975269 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44313499 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42737113 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.41975190 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.39611219 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.38204559 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.36640436 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.35477496 |
| 37 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.33395417 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.32714547 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30306503 |
| 40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.27905227 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.27213750 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.25161976 |
| 43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.23866223 |
| 44 | Galactose metabolism_Homo sapiens_hsa00052 | 1.22346461 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.19926984 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18381145 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.17634646 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.17345847 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.16546414 |
| 50 | Retinol metabolism_Homo sapiens_hsa00830 | 1.13294890 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13120215 |
| 52 | Tuberculosis_Homo sapiens_hsa05152 | 1.11799371 |
| 53 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.10034224 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 1.08805746 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.07827798 |
| 56 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.05186617 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.05184967 |
| 58 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.04083307 |
| 59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03480908 |
| 60 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.03249658 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 1.02681324 |
| 62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01351282 |
| 63 | Malaria_Homo sapiens_hsa05144 | 1.01309035 |
| 64 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.01276300 |
| 65 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.00925387 |
| 66 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99463262 |
| 67 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.99158605 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96181220 |
| 69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.94593842 |
| 70 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.92768345 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.90185972 |
| 72 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.87289104 |
| 73 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.86485112 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.85967539 |
| 75 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.85858582 |
| 76 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.85638374 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.85404933 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84857255 |
| 79 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84120819 |
| 80 | Allograft rejection_Homo sapiens_hsa05330 | 0.83995718 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83742658 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83510123 |
| 83 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83130169 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.83002459 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82831250 |
| 86 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.81762575 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.80526122 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.79306133 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78079755 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.77982738 |
| 91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76990956 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75982675 |
| 93 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.75876145 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.75843000 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73990836 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73420135 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71719925 |
| 98 | Measles_Homo sapiens_hsa05162 | 0.71257214 |
| 99 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.70975940 |
| 100 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.70682576 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70495282 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68613829 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.66057219 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65194564 |
| 105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65081609 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.64840854 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.61420665 |
| 108 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.61410516 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61259774 |
| 110 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61235055 |
| 111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61087557 |
| 112 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60427403 |
| 113 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60378748 |
| 114 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.60075376 |
| 115 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59891685 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59731047 |
| 117 | Renin secretion_Homo sapiens_hsa04924 | 0.59222364 |
| 118 | Prostate cancer_Homo sapiens_hsa05215 | 0.58777865 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58097013 |
| 120 | Axon guidance_Homo sapiens_hsa04360 | 0.57869747 |
| 121 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57859728 |
| 122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57624801 |
| 123 | Hepatitis B_Homo sapiens_hsa05161 | 0.57097866 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56875911 |
| 125 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.56072717 |
| 126 | Melanogenesis_Homo sapiens_hsa04916 | 0.55958230 |
| 127 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55837875 |
| 128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54554076 |
| 129 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.54348244 |
| 130 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53795053 |
| 131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53460035 |
| 132 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52115515 |
| 133 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51737163 |
| 134 | ABC transporters_Homo sapiens_hsa02010 | 0.51535148 |
| 135 | Carbon metabolism_Homo sapiens_hsa01200 | 0.51381470 |
| 136 | Gap junction_Homo sapiens_hsa04540 | 0.50488867 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50289947 |
| 138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50028159 |
| 139 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49807248 |
| 140 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49643803 |
| 141 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48931563 |
| 142 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48503391 |
| 143 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48418432 |
| 144 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48076037 |
| 145 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47702886 |
| 146 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46343485 |
| 147 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45991421 |
| 148 | Platelet activation_Homo sapiens_hsa04611 | 0.45689804 |
| 149 | Parkinsons disease_Homo sapiens_hsa05012 | 0.45496324 |
| 150 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.45083941 |
| 151 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.44972416 |
| 152 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.44549300 |
| 153 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44275964 |
| 154 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43788352 |
| 155 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43409465 |
| 156 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.42830496 |
| 157 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.41220496 |
| 158 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.40888296 |
| 159 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40066457 |
| 160 | Cocaine addiction_Homo sapiens_hsa05030 | 0.39490274 |
| 161 | Amoebiasis_Homo sapiens_hsa05146 | 0.39475581 |
| 162 | Pertussis_Homo sapiens_hsa05133 | 0.39199538 |
| 163 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39111575 |
| 164 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38610364 |
| 165 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35974732 |

